Sterling Capital Management »

Aktis Oncology shares owned by Sterling Capital Management

Quarter-by-quarter ownership of Aktis Oncology shares owned by Sterling Capital Management from 13F filings

Historical chart of Sterling Capital Management investment in Aktis Oncology

Tip: Access up to 7 years of quarterly data

All positions including Aktis Oncology held by Sterling Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aktis Oncology by Sterling Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $7.0k 393 17.89

More positions owned by Sterling Capital Management

Vanguard S&p 500 Etf Etf (VOO)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Manulife Co-investment Partner LP
Apple (AAPL)
Tq Db Pension Priv Inv Adm LP
Amazon (AMZN)
Charles Schwab Corporation (SCHW)
JPMorgan Chase & Co. (JPM)
Waste Management (WM)
Linde (LIN)
Analog Devices (ADI)
Motorola Solutions (MSI)
Abbvie (ABBV)
Southern Company (SO)

View all positions for Sterling Capital Management

Top funds holding Aktis Oncology

MPM Oncology Impact Management
EcoR1 Capital
BlackRock
RA Capital Management
Henderson Group
Baker Bros. Advisors
Octagon Capital Advisors
Merck & Co
Vanguard Capital Management
Geode Capital Management
Avidity Partners Management
AH Capital Management
UBS Group
Arrowpoint Asset Management
Alyeska Investment Group

View all funds holding Aktis Oncology